| Recruiting | Implementing Depression and Adherence Treatment NCT07032363 | University of Miami | N/A |
| Enrolling By Invitation | Engaging Pharmacists to Advance Tobacco Treatment Service Delivery NCT07501624 | Medical University of South Carolina | N/A |
| Not Yet Recruiting | The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and NCT07131826 | National Taiwan University Clinical Trial Center | — |
| Active Not Recruiting | ALHIV Smartphone Game Study NCT06913660 | Emory University | N/A |
| Recruiting | The Collaborative Care PrTNER Study NCT06585631 | Children's Hospital of Philadelphia | N/A |
| Completed | HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital Setting NCT06282328 | Castagna Antonella | — |
| Recruiting | A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Sahara NCT05373758 | Massachusetts General Hospital | N/A |
| Recruiting | Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage NCT05939167 | Cell Energy Life Sciences Group Co. LTD | Phase 1 / Phase 2 |
| Recruiting | Risk Identification Factors for Pulmonary Function Impairment in AIDS Patients Recovered From Severe Pneumonia NCT06137196 | Guangzhou 8th People's Hospital | — |
| Recruiting | Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies NCT06145841 | Guangzhou 8th People's Hospital | — |
| Not Yet Recruiting | The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH NCT06044792 | Medical University of Warsaw | — |
| Recruiting | Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients NCT05988879 | Guangzhou 8th People's Hospital | — |
| Recruiting | Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST) NCT06202898 | University of Central Florida | N/A |
| Unknown | The Living With a Long-Term Condition Study NCT06072287 | King's College London | — |
| Recruiting | Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV NCT06045923 | Centers for Disease Control and Prevention | — |
| Recruiting | Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot NCT05390424 | University Hospital, Rouen | N/A |
| Active Not Recruiting | The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events NCT05421286 | Rigshospitalet, Denmark | — |
| Completed | Effect of N-803 on B Cell Follicles in Antiretroviral Treated HIV Disease NCT04808908 | University of Minnesota | Phase 1 |
| Unknown | Community-Based Model for Delivery of Antiretroviral Therapy in Cambodia NCT04766710 | National University of Singapore | N/A |
| Completed | COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS NCT04754698 | University of Sao Paulo General Hospital | Phase 4 |
| Completed | Standardized Patients to Measure and Address Intersectional Stigma NCT04896216 | University of Minnesota | N/A |
| Completed | Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and HIV-Un-infected Women NCT03633721 | Albert Einstein College of Medicine | Phase 2 |
| Completed | Reducing Time to Spaced-out Appointments for Newly-diagnosed People Living With HIV NCT04567693 | Montefiore Medical Center | N/A |
| Unknown | Antiretroviral Adherence and Drug-level Monitoring NCT05996094 | Zamrotul Izzah | — |
| Unknown | Investigation of the Psychosocial Factors Responsible for the Late Recourse to HIV Testing Within MSM NCT03661203 | French National Agency for Research on AIDS and Viral Hepatitis | — |
| Completed | Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care NCT03670316 | University of Alabama at Birmingham | Phase 4 |
| Completed | Intervention Program to Address PTSD in People Living With HIV NCT05588596 | Central South University | N/A |
| Completed | Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients NCT04059770 | Alessandro Pasqualotto | Phase 2 |
| Withdrawn | N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV NCT04144335 | University of Minnesota | Phase 1 / Phase 2 |
| Completed | Adolescent to Adult Patient-centered HIV Transition (ADAPT) Study NCT02872805 | University of Maryland, Baltimore | N/A |
| Unknown | Treatment of PD-1 Inhibitor in AIDS-associated PML NCT04091932 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Completed | Effect on HIV Medications on EPC Cells NCT03782142 | Sabyasachi Sen | — |
| Unknown | Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis NCT03478033 | Shanghai Public Health Clinical Center | N/A |
| Unknown | An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients. NCT03517631 | Shanghai Public Health Clinical Center | Phase 1 |
| Completed | A Drug Safety and Dose-exploratory Clinical Study of Azvudine Tablets in Patients Who Have Not Received Anti-H NCT04109183 | Henan Genuine Biotech Co., Ltd. | Phase 2 |
| Completed | SSRI Effects on Depression and Immunity in HIV/AIDS NCT02620150 | University of Pennsylvania | Phase 4 |
| Completed | Resistance Testing to Improve Management of Virologic Failure in Sub-Saharan Africa NCT02787499 | Massachusetts General Hospital | N/A |
| Completed | Healing Hearts and Mending Minds in Older Adults Living With HIV NCT02711878 | Emory University | N/A |
| Completed | Perturbing of HIV Reservoir With Immune Stimulation NCT02707692 | University of California, San Diego | N/A |
| Terminated | Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin NCT01700790 | University of Miami | Phase 4 |
| Completed | Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/H NCT02641158 | Columbia University | N/A |
| Completed | Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes NCT04770701 | Trieu, Nguyen Thi, M.D. | Phase 4 |
| Completed | Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine NCT02284035 | Juan A. Arnaiz | Phase 3 |
| Completed | Atripla to Stribild Switch Study to Evaluate Sleep Disturbances NCT02477527 | Midtown Medical Center, Tampa, FL | Phase 4 |
| Completed | Supporting Attendance for Facility Delivery and Infant Health NCT03023033 | Elizabeth Glaser Pediatric AIDS Foundation | N/A |
| Completed | Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV NCT02606344 | NMP Medical Research Institute | N/A |
| Completed | Increasing Social Support to Improve HIV Care Engagement and Adherence in St. Petersburg, Russia NCT02167828 | Medical College of Wisconsin | N/A |
| Completed | A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma NCT02029430 | ImmunityBio, Inc. | Phase 2 |
| Completed | Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults NCT02099994 | University of Oxford | Phase 1 / Phase 2 |
| Completed | Test Albuvirtide in Experienced Patients NCT02369965 | Frontier Biotechnologies Inc. | Phase 3 |
| Completed | Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico NCT01792752 | Columbia University | N/A |
| Completed | Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study") NCT01985399 | Stanford University | — |
| Completed | RCT of CBT for Insomnia With PLWHA NCT02259101 | Emory University | N/A |
| Unknown | Zinc Supplementation Effect on Immune Recovery in HIV Patients NCT02162797 | CES University | N/A |
| Completed | Care4Today v2.0 Application for Improving Adherence to HIV Medications NCT02001064 | University of California, San Diego | N/A |
| Unknown | Smoking Cessation for People Living With HIV/AIDS NCT01965405 | Wayne State University | N/A |
| Completed | Depression Amongst HIV Positive Patients in Lilongwe NCT02646605 | University of North Carolina, Chapel Hill | — |
| Completed | Social Network Intervention to Engage Out-of-Care PLH Into Treatment NCT01825018 | Medical College of Wisconsin | N/A |
| Completed | Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests NCT01790633 | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | N/A |
| Unknown | Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein NCT01793818 | BIOSANTECH | Phase 1 / Phase 2 |
| Completed | Adherence Support Intervention for Persons Living With HIV/AIDS (PLWHA) on Antiretroviral Therapy (ART) in Est NCT01789138 | University of Tartu | N/A |
| Completed | Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users NCT01614106 | Columbia University | N/A |
| Completed | Switching Undetectables to Selzentry NCT01866267 | St. Hope Foundation | Phase 4 |
| Completed | Expansion to Interdisciplinary HIV Prevention in Women NCT01994603 | University of Oklahoma | N/A |
| Completed | Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Ti NCT01705223 | National Center for AIDS/STD Control and Prevention, China CDC | Phase 2 |
| Completed | Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users NCT01612169 | Columbia University | N/A |
| Completed | Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects NCT01610427 | GlaxoSmithKline | N/A |
| Completed | The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception NCT01667978 | University of Southern California | N/A |
| Completed | Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up NCT01667068 | University Hospital, Essen | — |
| Completed | Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men NCT01751594 | University of North Carolina, Chapel Hill | N/A |
| Completed | Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AI NCT01482923 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected NCT01348308 | ANRS, Emerging Infectious Diseases | Phase 3 |
| Completed | Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobact NCT01053598 | Epicentre | — |
| Unknown | Video-Based Delivery of HIV Test Information for Spanish-Speaking Latinos NCT01452555 | Rhode Island Hospital | Phase 3 |
| Completed | Exploring the Impact of HIV and ART on Knowledge, Attitudes and Practices in Reproductive Health in Lilongwe, NCT02667808 | Emory University | — |
| Completed | Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Ne NCT01419314 | Texas Woman's University | N/A |
| Completed | Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, a NCT01645865 | Elizabeth Glaser Pediatric AIDS Foundation | — |
| Completed | The VMVN Study: Virological Monitoring in Viet Nam NCT01317498 | Beth Israel Deaconess Medical Center | N/A |
| Completed | Personalized Text Messages to Improve Antiretroviral Treatment (ART) Adherence in HIV+ Methamphetamine Users NCT01317277 | University of California, San Diego | N/A |
| Unknown | HIV Liver Regeneration Project for HIV Patients With Cirrhosis by Autologous Bone Marrow Transplantation NCT01309594 | National Center for Global Health and Medicine, Japan | N/A |
| Completed | Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populat NCT01246401 | Yale University | Phase 1 / Phase 2 |
| Completed | Male Circumcision Services for HIV Prevention in the Dominican Republic NCT02337179 | University of Illinois at Chicago | N/A |
| Recruiting | The DC Cohort Longitudinal HIV Status Neutral Study NCT01206920 | George Washington University | — |
| Completed | Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With NCT01189695 | Bamrasnaradura Infectious Diseases Institute | Phase 4 |
| Completed | Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Person NCT01218113 | GlaxoSmithKline | Phase 2 |
| Completed | Cryptococcal Optimal ART Timing Trial NCT01075152 | University of Minnesota | Phase 4 |
| Completed | HIV/AIDS, Severe Mental Illness and Homelessness NCT01172704 | Boston Medical Center | Phase 2 |
| Unknown | Bioequivalence Study of Pediatric Formulations to Treat HIV Infection NCT01469520 | Elim Pediatric Pharmaceuticals Inc. | Phase 1 |
| Completed | Study Targeting Affect Regulation NCT01237366 | University of California, San Francisco | Phase 1 / Phase 2 |
| Completed | Alcohol Pharmacotherapy for HIV+ Prisoners NCT01077310 | Yale University | N/A |
| Completed | Adherence, Improvement Measure (AIM) System NCT01252212 | University of California, San Francisco | Phase 3 |
| Unknown | HIV Indicator Diseases Survey Across Europe - UK Arm NCT01196468 | Chelsea and Westminster NHS Foundation Trust | — |
| Withdrawn | A Semi-Factorial Cluster-Randomized Trial to Estimate the Effect Size of Community Mobilization and VCT Vans o NCT01160575 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine NCT01092611 | GlaxoSmithKline | Phase 1 |
| Completed | Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru NCT01070017 | Brigham and Women's Hospital | Phase 3 |
| Unknown | Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Ad NCT01013987 | Fundación Huésped | Phase 4 |
| Completed | Vitamin D Dose Finding Study NCT01092338 | Children's Hospital of Philadelphia | Phase 2 |
| Completed | A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs) NCT01106638 | Montefiore Medical Center | Phase 3 |
| Completed | Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose NCT00972725 | GlaxoSmithKline | Phase 2 |
| Completed | Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up NCT01196273 | University Hospital, Essen | — |
| Completed | Safety Study of Maraviroc's Effect on Human Osteoclasts NCT01428986 | National Center for Global Health and Medicine, Japan | — |
| Completed | Obesity in HIV After Antiretroviral Therapy NCT01461876 | Duke University | — |
| Completed | Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful N NCT01135251 | Neurotune AG | Phase 2 |
| Withdrawn | Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts NCT00951795 | Abbott RDx Cardiometabolic | — |
| Completed | Genotype Based Personalized Prescription of Nevirapine NCT00986063 | Surakameth Mahasirimongkol | Phase 4 |
| Completed | Cerebral Toxoplasmosis and AIDS NCT00803621 | University Hospital, Limoges | — |
| Completed | Pilot Study of a Raltegravir Based NRTI Sparing Regimen NCT00814879 | Yale University | N/A |
| Completed | HIV Cohort Study At Johns Hopkins University, University of North Carolina at Chapel Hill and Vanderbilt Unive NCT01339416 | ViiV Healthcare | — |
| Completed | Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old NCT00814762 | GlaxoSmithKline | Phase 1 |
| Completed | VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fuma NCT00828789 | Tibotec BVBA | Phase 1 |
| Unknown | Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China NCT01344148 | Shanghai Public Health Clinical Center | N/A |
| Completed | Kaiser Permanente HIV Cohort Study NCT01339403 | ViiV Healthcare | — |
| Completed | HIV and Kidney Function Study NCT00905151 | Tufts Medical Center | — |
| Completed | Acupuncture/Moxibustion (Acu/Moxa) for Distal Symmetric Peripheral Neuropathy (DSP) in HIV NCT00826345 | NYU Langone Health | N/A |
| Completed | TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 a NCT00740389 | Tibotec Pharmaceuticals, Ireland | Phase 1 |
| Completed | TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir i NCT00744887 | Tibotec Pharmaceuticals, Ireland | Phase 1 |
| Completed | A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected NCT00774683 | Kristine Patterson, MD | — |
| Completed | TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women. NCT00739622 | Tibotec Pharmaceuticals, Ireland | Phase 1 |
| Completed | TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately I NCT00736905 | Tibotec Pharmaceuticals, Ireland | Phase 1 |
| Completed | HIV Prevention for Injecting Drug Users in Kazakhstan NCT01690442 | Columbia University | Phase 2 |
| Completed | Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc NCT00853840 | ViiV Healthcare | Phase 4 |
| Unknown | Social-Psychological Intervention to Improve Adherence to HAART NCT00716040 | University of Sao Paulo | N/A |
| Terminated | Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treat NCT00737724 | Instituto Nacional de Enfermedades Respiratorias | N/A |
| Completed | Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Ther NCT00661960 | University of California, Davis | N/A |
| Completed | Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoenc NCT03969550 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Completed | Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) NCT00495326 | French National Agency for Research on AIDS and Viral Hepatitis | Phase 2 / Phase 3 |
| Completed | Predictors of Neuro-cognitive Decline and Survival in HIV-infected Subjects NCT00864292 | SEARCH Research Foundation | — |
| Completed | HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers NCT00491335 | National Cancer Institute (NCI) | — |
| Completed | The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya NCT01058694 | Georgetown University | N/A |
| Completed | Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya NCT00830622 | University of Manitoba | N/A |
| Completed | EuroSIDA As An External Comparator To MOTIVATE Trials NCT01329783 | ViiV Healthcare | — |
| Completed | Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative NCT00434512 | GlaxoSmithKline | Phase 2 |
| Completed | HIV Viral Load Monitoring in Resource-Poor Settings NCT00929604 | University of Alabama at Birmingham | N/A |
| Completed | Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients NCT00346697 | Brown, Todd, M.D., Ph.D. | Phase 4 |
| Withdrawn | Pharmacokinetics and Pharmacodynamics of an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian Populations NCT00347750 | Rambam Health Care Campus | — |
| Completed | Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL) NCT00301561 | French National Agency for Research on AIDS and Viral Hepatitis | Phase 3 |
| Completed | Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130) NCT00302822 | French National Agency for Research on AIDS and Viral Hepatitis | Phase 3 |
| Completed | Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina NCT00122538 | French National Agency for Research on AIDS and Viral Hepatitis | Phase 2 |
| Completed | A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort NCT00268827 | AIDS Arms Inc. | Phase 4 |
| Unknown | High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disea NCT00247143 | Lampiris, Harry W., M.D. | N/A |
| Completed | Buprenorphine and Integrated HIV Care NCT00317460 | Yale University | Phase 4 |
| Withdrawn | HLA-B35 Alleles and AIDS NCT00340223 | National Cancer Institute (NCI) | — |
| Completed | Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome NCT00342602 | National Cancer Institute (NCI) | — |
| Unknown | Buprenorphine and Integrated HIV Care Evaluation NCT00124358 | The New York Academy of Medicine | Phase 4 |
| Completed | The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration NCT00227357 | Ruth M. Rothstein CORE Center | — |
| Withdrawn | Effect of Repeated Exposures to Compressed Air on Patients With AIDS NCT00444847 | Designed Altobaric Technology, Incorporated | Phase 2 |
| Unknown | Pediatric Nevirapine Resistance Study NCT00117728 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 3 |
| Completed | Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS NCT00106795 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Comparison of Facility and Home-based ART Delivery Systems in Uganda NCT00144365 | Centers for Disease Control and Prevention | Phase 3 |
| Completed | Exercise and Pioglitazone for HIV-Metabolic Syndromes NCT00639457 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A |
| Completed | NOW Thai HAART Study NCT00367731 | Department of Medical Services Ministry of Public Health of Thailand | — |
| Terminated | Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023) NCT00095576 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis NCT00341172 | National Cancer Institute (NCI) | — |
| Completed | Motivating HIV+ Women: Risk Reduction and ART Adherence NCT00253045 | Emory University | N/A |
| Completed | Housing and Health Study NCT00153504 | Centers for Disease Control and Prevention | N/A |
| Unknown | Once Daily 3TC, Efavirenz and ddI for HIV Infection NCT00214435 | 407 Doctors | Phase 4 |
| Completed | Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission NCT00213083 | Population Council | Phase 3 |
| Completed | To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine NCT00207168 | Bristol-Myers Squibb | Phase 4 |
| Completed | Physiologic Growth Hormone Effects in HIV Lipodystrophy NCT00100698 | Massachusetts General Hospital | N/A |
| Completed | Long Term Treatment Interruptions NCT00433056 | A.O. Ospedale Papa Giovanni XXIII | Phase 3 |
| Completed | Relaxation Response With Acupuncture for HIV Patients NCT00064740 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression NCT00344981 | University of Maryland, Baltimore | N/A |
| Completed | Treatment of Cerebral Toxoplasmosis in HIV/AIDS NCT00367081 | Department of Medical Services Ministry of Public Health of Thailand | Phase 4 |
| Completed | Massage to Increase Well-Being and Immune Function in Dominican Children Infected With HIV NCT00070980 | National Center for Complementary and Integrative Health (NCCIH) | N/A |
| Completed | HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT NCT00380770 | University of KwaZulu | Phase 4 |
| Completed | The Adult Antiretroviral Treatment and Resistance Study (Tshepo) NCT00197613 | Harvard School of Public Health (HSPH) | Phase 3 |
| Completed | L-Carnitine to Treat Fatigue in AIDS Patients NCT00079599 | National Institute of Nursing Research (NINR) | Phase 2 |
| Completed | In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults NCT00144352 | Centers for Disease Control and Prevention | Phase 4 |
| Completed | Reducing HIV Risk Among Mexican Youth NCT01084395 | University of Michigan | N/A |
| Completed | Lactate Metabolism Study in HIV Infected Persons NCT00202228 | Queen's University | Phase 4 |
| Terminated | Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort NCT00340548 | National Cancer Institute (NCI) | — |
| Completed | DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Prev NCT00116415 | Bristol-Myers Squibb | N/A |
| Completed | Phase III PEG-Intron in HIV-infected Patients (Study P00738) NCT00035360 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Pre NCT00116116 | Bristol-Myers Squibb | Phase 4 |
| Completed | Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection NCT00113126 | University Hospital, Geneva | N/A |
| Completed | Socioenvironmental Determinants of Psychological Functioning, Mental Health and AIDS in Mali NCT00339391 | National Institute of Mental Health (NIMH) | — |
| Completed | Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) NCT00116298 | Bristol-Myers Squibb | Phase 3 |
| Completed | CSP #512 - Options in Management With Anti-Retrovirals NCT00050089 | US Department of Veterans Affairs | N/A |
| Completed | Distant Healing for HIV/AIDS NCT00079534 | National Center for Complementary and Integrative Health (NCCIH) | N/A |
| Completed | The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS NCT00202241 | Queen's University | N/A |
| Completed | AIDS and Cancer Specimen Bank (ACSB) NCT00587912 | Memorial Sloan Kettering Cancer Center | — |
| Enrolling By Invitation | EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV NCT02699736 | Rigshospitalet, Denmark | — |
| Completed | Study of Enfuvirtide in HIV-Positive Subjects NCT00086710 | Trimeris | Phase 1 |